April 20, 2014 9:56 AM ET

Pharmaceuticals

Company Overview of Proteostasis Therapeutics, Inc.

Executive Profile

Alfred L. Goldberg Ph.D.

Director, Member of Science & Technology Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee, Repligen Corporation
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 8 different industries.

See Board Relationships
70$95,001

Background

Dr. Alfred L. Goldberg, Ph.D. serves as Member of Scientific Advisory Board of Proteostasis Therapeutics, Inc. Dr. Goldberg was Founder of ProScript. Dr. Goldberg is internationally renowned as a cell biologist and has consulted regularly for major biotechnology companies. Dr. Goldberg is a renowned scientist noted in particular for elucidating the structure and function of the proteasome which established the mechanism by which most proteins are destroyed in cells. ...

Corporate Headquarters

200 Technology Square
Cambridge, Massachusetts 02139

United States

Phone: 617-225-0096
Fax: 617-632-5739

Board Members Memberships

Director and Member of the Scientific Advisory Board
2008-Present
Director, Member of Science & Technology Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education

PhD 1968
Harvard University
BA 1963
Harvard University
Unknown/Other Education
University of Cambridge
Unknown/Other Education
Harvard College
BA 1963
Harvard College
Unknown/Other Education
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$45,000
Total Calculated Compensation$95,001
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Proteostasis Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.